XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.24.3

Balance Sheet Details | 9 Months Ended
--- | ---
Sep. 30, 2024
Balance Sheet Details |
Balance Sheet Details | 6. Balance Sheet Details Property and Equipment Property and equipment as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, 2024 |  | December 31, 2023
Laboratory equipment | ​ | $ | 21,311 | ​ | $ | 19,678
Furniture and fixtures | ​ | ​ | 831 | ​ | ​ | 817
Office and computer equipment | ​ |  | 438 | ​ |  | 438
Leasehold improvements | ​ |  | 3,802 | ​ |  | 3,447
Total | ​ | ​ | 26,382 | ​ | ​ | 24,380
Less: accumulated depreciation | ​ |  | (12,766) | ​ |  | (11,821)
Property and equipment, net | ​ | $ | 13,616 | ​ | $ | 12,559
​ Depreciation and amortization expense totaled $0.3 million and $0.2 million for the three months ended September 30, 2024 and 2023, and $0.9 and $0.7 million for the nine months ended September 30, 2024 and 2023, respectively. Construction in progress and fixed assets not in use were $9.6 million and $8.1 million as of September 30, 2024 and December 31, 2023, respectively, and are included in the laboratory equipment in the table above. These assets are not depreciated until they are placed in service. Other receivables Other receivables as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2024 |  | December 31, 2023
Tenant improvement allowance receivable (Note 12) | ​ | $ | 597 | ​ | $ | 1,835
Grant and award receivable (Note 13) | ​ | ​ | 1,622 | ​ | ​ | 1,528
​ | ​ | $ | 2,219 | ​ | $ | 3,363
​ Accounts payable and accrued liabilities Accounts payable and accrued liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2024 |  | December 31, 2023
Accounts payable | ​ | $ | 1,815 | ​ | $ | 1,585
Accrued clinical trial expenses | ​ | ​ | 1,567 | ​ | ​ | 3,021
Other accrued expenses | ​ | ​ | 332 | ​ | ​ | 1,083
​ | ​ | $ | 3,714 | ​ | $ | 5,689
​

X
- References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/360/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 6 -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 7 -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7 + Details
Name: | us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration